For this thesis we have performed preclinical studies in laboratory animals with the ultimate aim to improve PRRT. The aims of the studies presented in this thesis were to:
1 Evaluate tumour responses after a combination of PRRT with the mTOR inhibitor everolimus (RAD001)
2 Evaluate tumour responses after a combination of PRRT and the chemotherapeutic temozolomide and optimize the treatment scheme
3 Evaluate the effects of different treatment schemes and different molar activities on tumour responses and dosimetry of tumour and organs.

Additional Metadata
Promotor M. de Jong (Marion) , M.R. Bernsen (Monique) , M.K. Konijnenberg (Mark K.)
Publisher Erasmus University Rotterdam
ISBN 978-94-6332-387-1
Persistent URL hdl.handle.net/1765/109689
Citation
Bison, S.M. (2018, September 4). Combination treatments and dose optimization to enhance peptide receptor radionuclide therapy. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/109689